Literature DB >> 6164954

Interferon responses of leukocytes in multiple sclerosis.

P A Neighbour, A E Miller, B R Bloom.   

Abstract

In vitro interferon (IFN) responses of peripheral blood leukocytes to measles virus and to other IFN inducers were determined for multiple sclerosis patients and normal donors. The group mean IFN response to measles virus was significantly lower in patients (15 units) than in normal donors (100 units), and a greater proportion of the patients failed to exhibit a significant IFN response. This defect was not specific for measles virus and was also observed consistently in response to Newcastle disease virus, Poly(I).Poly(C), and concanavalin A. The level of IFN response was not related to the clinical stage of disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164954     DOI: 10.1212/wnl.31.5.561

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology.

Authors:  Vincent C Lombardi; Svetlana F Khaiboullina
Journal:  Clin Immunol       Date:  2014-04-24       Impact factor: 3.969

Review 2.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

3.  Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.

Authors:  S Inogés; J Merino; E Bandrés; P De Castro; M L Subirá; A Sánchez-Ibarrola
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

4.  Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.

Authors:  J C Craig; S A Hawkins; M W Swallow; J A Lyttle; V H Patterson; J D Merrett; M Haire
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

5.  Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results.

Authors:  C Milanese; A Salmaggi; L La Mantia; A Campi; M Eoli; M Savoiardo; G Bianchi; A Nespolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

6.  Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.

Authors:  A M Liberati; M Horisberger; M Schippa; F Di Clemente; M Fizzotti; S Filippo; M G Proietti; S Arzano; P Berruto; L Palmisano
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 7.  Interferon-beta treatment for multiple sclerosis.

Authors:  Robert A Bermel; Richard A Rudick
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

8.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

9.  Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donors.

Authors:  G Vervliet; H Deckmyn; H Carton; A Billiau
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

10.  Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.

Authors:  S Haahr; A Møller-Larsen; E Pedersen
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.